<html>
<head>PUBMED IDs for CEM15</head>
<body bgcolor='#C5F0F2'><h1>CEM15</h1><a href='https://pubmed.ncbi.nlm.nih.gov/12167863/'>Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein.</a> August 9  2002<br><a href='https://pubmed.ncbi.nlm.nih.gov/12719574/'>Comprehensive investigation of the molecular defect in vif-deficient human immunodeficiency virus type 1 virions.</a> April 30  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/12808466/'>Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts.</a> June 17  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/12808465/'>The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA.</a> June 17  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/12809610/'>DNA deamination mediates innate immunity to retroviral infection.</a> June 18  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/12859895/'>Species-specific exclusion of APOBEC3G from HIV-1 virions by Vif.</a> July 16  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/12859878/'>[Detection of 29 types of fusion gene in leukemia by multiplex RT-PCR].</a> July 16  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/12859877/'>[Transfection of chk1/2 antisense oligonucleotide to HL-60 cell line increases the apoptotic sensitivity to irradiation].</a> July 16  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/12859872/'>[Detection of bcr/abl fusion gene in chronic myeloid leukemia by fluorescence in situ hybridization and nested reverse transcription polymerase chain reaction].</a> July 16  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/12859871/'>[Effect of endogenous TGF-beta1 and TNF-alpha on the As(2)O(3) inducing apoptosis of HL-60 cells].</a> July 16  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/12859866/'>[Effect of liposomal transfection of cyclin A antisense oligodeoxynucleotide (ASON) on HL-60 cell proliferation and apoptosis].</a> July 16  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/12859795/'>Sensitivity and fidelity of DNA microarray improved with integration of Amplified Differential Gene Expression (ADGE).</a> July 16  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/12859771/'>Adaptation to high salt in Lactobacillus: role of peptides and proteolytic enzymes.</a> July 16  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/12859767/'>ompU genes in non-toxigenic Vibrio cholerae associated with aquaculture.</a> July 16  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/12859744/'>p53 alterations in porokeratosis.</a> July 16  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/12859741/'>Sezary syndrome: cutaneous immunoperoxidase double-labeling technique demonstrates CD4/CD8 ratio non-specificity.</a> July 16  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/12859695/'>Oestrogen receptor alpha gene polymorphism is related to aortic valve sclerosis in postmenopausal women.</a> July 16  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/12970355/'>The enzymatic activity of CEM15/Apobec-3G is essential for the regulation of the infectivity of HIV-1 virion but not a sole determinant of its antiviral activity.</a> September 13  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/14527406/'>HIV-1 Vif blocks the antiviral activity of APOBEC3G by impairing both its translation and intracellular stability.</a> October 7  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/14557625/'>The human immunodeficiency virus type 1 Vif protein reduces intracellular expression and inhibits packaging of APOBEC3G (CEM15), a cellular inhibitor of virus infectivity.</a> October 15  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/14564014/'>Induction of APOBEC3G ubiquitination and degradation by an HIV-1 Vif-Cul5-SCF complex.</a> October 18  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/14672928/'>Vif overcomes the innate antiviral activity of APOBEC3G by promoting its degradation in the ubiquitin-proteasome pathway.</a> December 16  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/14747572/'>Influence of primate lentiviral Vif and proteasome inhibitors on human immunodeficiency virus type 1 virion packaging of APOBEC3G.</a> January 30  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/14966139/'>A single amino acid determinant governs the species-specific sensitivity of APOBEC3G to Vif action.</a> February 18  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/15054139/'>A single amino acid substitution in human APOBEC3G antiretroviral enzyme confers resistance to HIV-1 virion infectivity factor-induced depletion.</a> April 1  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/15210352/'>Camelized rabbit-derived VH single-domain intrabodies against Vif strongly neutralize HIV-1 infectivity.</a> June 24  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/15296757/'>APOBEC3F properties and hypermutation preferences indicate activity against HIV-1 in vivo.</a> August 7  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/15609224/'>Exhaustive genotyping of the CEM15 (APOBEC3G) gene and absence of association with AIDS progression in a French cohort.</a> December 21  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/15613310/'>Functional analysis of Vif protein shows less restriction of human immunodeficiency virus type 2 by APOBEC3G.</a> December 23  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/17036163/'>High expression of APOBEC3G in patients infected with hepatitis C virus.</a> October 13  2006<br></body></html>
